(Reuters) -Shares of Gilead rose nearly 3% after the U.S. Supreme Court on Friday preserved a key element of the Obamacare ...

Myocarditis, when the heart muscle gets inflamed, can make it harder for the heart to pump blood possibly causing chest pain, ...

FRIDAY, June 27, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and ...

Prescribing information from the two drugmakers – Moderna and Pfizer – already advises doctors about the issue. But the FDA sent letters this spring to the drugmakers, requesting they update and ...

The University of Maryland School of Medicine (UMSOM) is pleased to formally acknowledge the 11 newest members of ...

A motion of censure against the European Commission led by Ursula von der Leyen was submitted on Thursday, June 26, by far-right member of the European Parliament Gheorghe Piperea, part of the ...

You can also apply for accelerator programmes that will help guide you through the early days of startup life, and some ...

Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

Pfizer has earned a consensus rating of “Moderate Buy” from fifteen analysts, with only one calling it a “sell.” The average ...

Using the ProFoundry platform and Novartis' expertise, the partners will identify novel proteins and drug targets for cardiovascular disease.

Pfizer announces positive results from phase 3 BASIS study of Hympavzi in haemophilia A or B with inhibitors: New York Friday, June 27, 2025, 10:00 Hrs [IST] Pfizer Inc. announced ...

They synergy of industry, academic institutions and state agencies fosters innovation and strengthens Ireland’s ...